As more invasive cells express more ITGA5 on their surface [12] and secrete EVs with more ITGB1, the role of FN1-α5β1 in the GBM tumour microenvironment should be further delineated as it may offer an attractive therapeutic target. The gene discussed is ITGA5; the disease is neoplasm.